US$ 24.71
glp 1 drugs fda approved for weight loss What to Make of the GLP-1 Coverage and Cost Landscape What's New in Obesity Treatment?
Description
doi: 10.2337/dc15-2727 277 HardingJJGaneaE
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
Longer-acting formulations with monthly dosing aim to reduce treatment burden and improve adherence

& Kirkpatrick, P
To view or add a comment, sign in DRESS Syndrome: A Rare but Potentially Life-Threatening Drug Reaction As healthcare professionals, we frequently administer medications that improve and save lives

However, due to its invasiveness, it should be offered preferentially to patients with exhausted non-pharmacological and pharmacological treatment options

Crucially, this action is glucose-dependent, meaning it primarily happens when blood sugar levels are high, such as after a meal
